Invex Therapeutics Ltd (ASX:IXC)
Australia
· Delayed Price · Currency is AUD
0.110
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST
Invex Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -0.84 | -0.48 | -1.64 | -7.75 | -3.95 | -2.28 | |
| Stock-Based Compensation | 0.02 | 0.02 | 0.14 | 0.48 | 0.35 | 0.56 | |
| Other Operating Activities | -0.16 | 0.02 | -0.04 | 0.02 | 0 | 0 | |
| Change in Accounts Receivable | -0 | -0 | 0.24 | -0.19 | -0.12 | 0.1 | |
| Change in Accounts Payable | -0.21 | -0.21 | -1.14 | 0.57 | 0.35 | -0.05 | |
| Operating Cash Flow | -1.19 | -0.65 | -2.44 | -6.87 | -3.38 | -1.68 | |
| Issuance of Common Stock | - | - | - | - | - | 8.65 | |
| Repurchase of Common Stock | - | - | -14 | - | - | - | |
| Other Financing Activities | - | - | - | - | - | -0.55 | |
| Financing Cash Flow | - | - | -14 | - | - | 8.09 | |
| Foreign Exchange Rate Adjustments | -0.02 | 0 | - | - | - | - | |
| Net Cash Flow | -1.21 | -0.65 | -16.45 | -6.87 | -3.38 | 6.42 | |
| Cash Income Tax Paid | - | -0.23 | -1.21 | -0.46 | - | - | |
| Levered Free Cash Flow | -1.05 | -0.64 | -2.1 | -4.48 | -1.95 | -2.23 | |
| Unlevered Free Cash Flow | -1.05 | -0.64 | -2.1 | -4.48 | -1.95 | -2.23 | |
| Change in Working Capital | -0.21 | -0.21 | -0.9 | 0.38 | 0.22 | 0.04 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.